Skip to main content
Gut logoLink to Gut
. 1985 Feb;26(2):208–211. doi: 10.1136/gut.26.2.208

Haemodialysis in 'hepatorenal syndrome': report on two cases.

F Keller, K Wagner, T Lenz, W Pommer, G Hahn, M Molzahn, P H Krause
PMCID: PMC1432414  PMID: 3967839

Abstract

We report two patients with hepatorenal syndrome who recovered from oliguria and renal failure after temporary treatment with haemodialysis. Hepatorenal syndrome developed under diuretic treatment in both patients. Volume expansion, dopamine, and prostaglandin I2 did not improve renal function. In the one patient with alcoholic cirrhosis, renal biopsy showed only minimal alterations of glomeruli, tubuli, and arterial vessels. In the other case, the deterioration and improvement in renal function parallelled changes in acute alcohol-toxic hepatic function. We conclude that haemodialysis should be considered for treatment of hepatorenal syndrome in selected patients where reversal of liver failure can be expected.

Full text

PDF
208

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Glassock R. J., Goldstein D. A., Collins J., Epstein M. Renal dysfunction in a 38-year-old man with hepatic failure. Am J Nephrol. 1983 Jan-Feb;3(1):44–49. doi: 10.1159/000166687. [DOI] [PubMed] [Google Scholar]
  2. Grosberg S. J., Wapnick S., Leveen H., Reddy A. N. Hepatorenal syndrome. Reversal with LeVeen shunt. N Y State J Med. 1978 Mar;78(4):637–639. [PubMed] [Google Scholar]
  3. Iwatsuki S., Popovtzer M. M., Corman J. L., Ishikawa M., Putnam C. W., Katz F. H., Starzl T. E. Recovery from "hepatorenal syndrome" after orthotopic liver transplantation. N Engl J Med. 1973 Nov 29;289(22):1155–1159. doi: 10.1056/NEJM197311292892201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Koppel M. H., Coburn J. W., Mims M. M., Goldstein H., Boyle J. D., Rubini M. E. Transplantation of cadaveric kidneys from patients with hepatorenal syndrome. Evidence for the functionalnature of renal failure in advanced liver disease. N Engl J Med. 1969 Jun 19;280(25):1367–1371. doi: 10.1056/NEJM196906192802501. [DOI] [PubMed] [Google Scholar]
  5. Ring-Larsen H. Hepatic nephropathy, related to haemodynamics. Liver. 1983 Oct;3(5):265–289. doi: 10.1111/j.1600-0676.1983.tb00879.x. [DOI] [PubMed] [Google Scholar]
  6. Vincenti F., Goldberg L. I. Combined use of dopamine and prostaglandin A1 in patients with acute renal failure and hepatorenal syndrome. Prostaglandins. 1978 Mar;15(3):463–472. doi: 10.1016/0090-6980(78)90130-2. [DOI] [PubMed] [Google Scholar]
  7. Wilson J. R. Dopamine in the hepatorenal syndrome. JAMA. 1977 Dec 19;238(25):2719–2720. [PubMed] [Google Scholar]
  8. Wong P. Y., McCoy G. C., Spielberg A., Milora R. V., Balint J. A. The hepatorenal syndrome. Gastroenterology. 1979 Dec;77(6):1326–1334. [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES